← Medication & Supplement Reference

VETERINARY TEAM REFERENCE · MEDICATION

Fluticasone propionate

Updated October 26, 2026 · Sources and review status below

For veterinarians and veterinary staff. Product-label information is distinct from extra-label clinical practice. This is not a complete prescribing formulary or an automated interaction screen. Verify the current label, exact formulation, patient and species-specific clinical reference before use. Independent veterinary/pharmacy review remains pending.

Prescribing overview

Inhaled glucocorticoid controller with veterinary airway-disease studies in cats, dogs and horses; nasal products are a separate presentation.

Inhaled/intranasal glucocorticoidProduct-specific clinical reference

A controller anti-inflammatory; it does not rapidly reverse bronchospasm.

Key prescribing checks

  • Feline pilot clinical research documented improvement; equine research demonstrated reduced airway hyperresponsiveness.
  • Canine deposition and endocrine studies support inhaled exposure research, not a universal efficacy claim.

Uses by species

Approval and evidence apply to the named product, species, route and indication. An extra-label use requires its own prescribing assessment; a human indication is not an animal approval.

Cats

Extra-label veterinary evidence; not an animal product approval

Asthma, inhaled

Small randomized pilot trial evaluated naturally occurring disease.

Use / indication source ↗

Horses

Extra-label veterinary evidence; not an animal product approval

Inflammatory airway disease, inhaled

Trial improved bronchoprovocation measures without significant clinical-score improvement.

Use / indication source ↗

Dogs

Extra-label veterinary evidence; not an animal product approval

Inhaled deposition/endocrine research

Healthy-dog studies do not establish every clinical indication.

Use / indication source ↗

Pharmacology & pharmacokinetics

Mechanism and clinical role

Glucocorticoid anti-inflammatory effects.

Absorption, distribution, metabolism and elimination

CYP3A4 metabolism permits increased systemic exposure with strong inhibitors. Canine lung deposition depends on delivery technique.

SAFETY REFERENCE · PRODUCT & SPECIES SPECIFIC

Contraindications & cautions

Contraindications identify circumstances where the source says a product should not be used. Precautions call for assessment or monitoring. Interactions identify combinations to review. They are distinct categories; this summary does not replace a full interaction check or the current product label.

Fluticasone Propionate HFA

Human oral-inhalation label; veterinary use is extra-label.

Contraindications · when not to use

  • Ingredient hypersensitivity; primary treatment of acute severe asthma.

Precautions & monitoring

  • Local fungal infection, adrenal suppression and infection risk require assessment.

Fluticasone Propionate Nasal Spray

Human intranasal label; not an inhaler substitute.

Contraindications · when not to use

  • Component hypersensitivity.

Precautions & monitoring

  • Nasal bleeding/ulceration, infection and systemic steroid effects require review.

No animal restriction is inferred solely from the human product label.

Safety sources checked: . Selected label information; independent veterinary or veterinary-pharmacy review remains pending. A label for dogs, cats, horses or humans does not establish safety for another species.

Adverse effects

Human-label concerns include oral fungal infection and systemic adrenal effects; veterinary frequency is not established.

These are selected source-reported effects, not incidence estimates or an exhaustive list. Spontaneous postmarketing reports do not by themselves establish frequency or causality.

Dosing & administration

Verify the source before prescribing. The regimens below summarize selected veterinary product labels, not every accepted veterinary use. They are not automatic substitutions between brands or formulations. Renal/hepatic disease, concurrent therapy, age, indication and clinical response can require a different plan.

A verified veterinary dose has not been entered for this product. Human-label dosing must not be used as an animal regimen. Consult a current species-specific clinical source and the prescribing veterinarian.

No animal dosing is supplied. The veterinarian must select the exact formulation, delivery device and individual regimen.

Extra-label prescribing and food-animal residue requirements are separate from labeled regimens. FDA extra-label-use guidance ↗

Drug & supplement interactions

This monograph summarizes selected interactions. The comparison tool applies a curated set of rules and is not comprehensive. Reconcile prescription drugs, nonprescription products, supplements and recent treatment changes.

Compare with other medications and check species →

Fluticasone Propionate HFA

Human oral-inhalation label; veterinary use is extra-label.

  • Strong CYP3A4 inhibitors, including itraconazole, are not recommended by the human label.
Interaction source ↗

Fluticasone Propionate Nasal Spray

Human intranasal label; not an inhaler substitute.

  • Strong CYP3A4 inhibitors can increase systemic steroid effects.
Interaction source ↗

Monitoring

Airway control and need for rescue treatment.

Veterinarian review for local infection and steroid-related systemic effects.

Client counseling

Use the exact prescribed inhaler and species-appropriate delivery device.

Nasal spray and combination inhalers are not substitutes; breathing distress needs urgent veterinary care.

This section supports the veterinary team's discharge discussion; it does not replace the product’s Client Information Sheet where one is required.

Storage & handling

Follow current canister priming, cleaning and storage instructions.

Brands, formulations & ingredient identity

Active ingredients

Fluticasone propionate

Other searchable names: fluticasone propionate HFA · Flovent · Flixotide · Flonase

This record is fluticasone propionate, not fluticasone furoate.

HFA oral-inhalation aerosol and nasal spray use different routes and devices; a nasal spray is not an asthma inhaler.

Brand names and availability vary; verify the active ingredient and current product.

Shared ingredients do not establish interchangeable concentrations, routes, release properties, species labeling or regional availability.

Fluticasone Propionate HFA

Formulation
Metered-dose inhalation aerosol
Label / product scope
Human product

Human product; veterinary use requires a prescription. Flovent-type single-ingredient controller.

Product label / source ↗

Fluticasone Propionate Nasal Spray

Formulation
Intranasal metered spray
Label / product scope
Human product

Human product; veterinary use requires a prescription. Flonase-type presentation; not interchangeable with HFA.

Product label / source ↗

References & review status

Clinical reference updated October 26, 2026. Independent veterinary or veterinary-pharmacy review not yet completed. Evidence gaps remain explicitly identified; this page does not claim equivalence to a comprehensive, professionally reviewed veterinary formulary.

Search another medication or supplement →

CONTINUE EXPLORING

Use these connected guides to prepare informed questions for your veterinary team.

Find Veterinary Care Near YouLocate general practices, urgent-care clinics, emergency hospitals and specialists.Read resource →When It Is an EmergencyRecognize signs that require immediate veterinary care.Read resource →Interactive Symptom NavigatorStart with what you notice and understand when to seek help.Read resource →Poisons and Household HazardsRecognize common exposures and avoid unsafe home treatment.Read resource →Printable Owner ToolkitBring observations, medication details and questions to your appointment.Read resource →
Privacy & cookie choices